10q10k10q10k.net
BGM Group Ltd.

BGM Group Ltd.BGMEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations
Q2 2025Q4 2024Q2 2024Q2 2023Q2 2022

BGM Q2 FY2025 Key Financial Metrics

Revenue

$29.2M

Gross Profit

$2.3M

Operating Profit

$210.6K

Net Profit

$439.4K

Gross Margin

7.9%

Operating Margin

0.7%

Net Margin

1.5%

YoY Growth

N/A

BGM Group Ltd. Q2 FY2025 Financial Summary

BGM Group Ltd. reported revenue of $29.2M for Q2 FY2025, with a net profit of $439.4K (1.5% margin). Cost of goods sold was $26.9M, operating expenses totaled $2.1M.

Key Financial Metrics

Total Revenue$29.2M
Net Profit$439.4K
Gross Margin7.9%
Operating Margin0.7%
Report PeriodQ2 FY2025

Revenue Breakdown

BGM Group Ltd. Q2 FY2025 revenue of $29.2M breaks down across 2 segments, led by Other at $17.4M (59.5% of total).

SegmentRevenue% of Total
Other$17.4M59.5%
Cost of revenue$11.8M40.5%

BGM Group Ltd. Revenue by Segment — Quarterly Trend

BGM Group Ltd. revenue by segment across the last 4 reported quarters, showing how each business line (such as Other and Cost of revenue) has evolved quarter over quarter.

SegmentQ2 FY2025Q4 FY2024Q2 FY2024Q2 FY2023
Other$17.4M—$8.4M—
Cost of revenue$11.8M—$11.1M—

BGM Group Ltd. Quarterly Revenue & Net Profit History

BGM Group Ltd. results over the last 5 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q2 FY2025$29.2M—$439.4K1.5%
Q4 FY2024$22.8M—N/AN/A
Q2 FY2024$32.1M—$249.7K0.8%
Q2 FY2023$32.1M—$249.7K0.8%
Q2 FY2022$29.9M—$2.2M7.5%

Income Statement

Q2 2022Q2 2023Q2 2024Q4 2024Q2 2025
Revenue$29.9M$32.1M$32.1M$22.8M$29.2M
YoY GrowthN/AN/AN/AN/AN/A

Balance Sheet

Q2 2022Q2 2023Q2 2024Q4 2024Q2 2025
Assets$75.4M$64.5M$49.9M$26.0M$207.4M
Liabilities$18.7M$9.6M$4.9M$16.2M$23.9M
Equity$54.9M$53.1M$43.4M$9.8M$182.1M

Cash Flow

Q2 2022Q4 2024
Operating CF$4.2M$-5.1M